Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Clene (CLNN) Shares Issued (2020 - 2025)

Clene has reported Shares Issued over the past 6 years, most recently at -$8.2 million for Q4 2025.

For Q4 2025, Shares Issued fell 317.16% year-over-year to -$8.2 million; the TTM value through Dec 2025 reached $30000.0, down 75.81%, while the annual FY2024 figure was $124000.0, N/A changed from the prior year.
Shares Issued for Q4 2025 was -$8.2 million at Clene, down from $3.3 million in the prior quarter.
Over five years, Shares Issued peaked at $4.5 million in Q1 2023 and troughed at -$8.2 million in Q4 2025.
A 5-year average of $48466.7 and a median of $100000.0 in 2022 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: surged 1518.18% in 2022 and later plummeted 1684.51% in 2023.
Year by year, Shares Issued stood at $11000.0 in 2021, then surged by 1518.18% to $178000.0 in 2022, then plummeted by 2628.09% to -$4.5 million in 2023, then skyrocketed by 56.09% to -$2.0 million in 2024, then crashed by 317.16% to -$8.2 million in 2025.
Business Quant data shows Shares Issued for CLNN at -$8.2 million in Q4 2025, $3.3 million in Q3 2025, and $2.3 million in Q2 2025.